Condition
Death, Assisted
Total Trials
3
Recruiting
0
Active
0
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
Trial Status
Unknown2
Completed1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (3)
Showing 3 of 3 trials
NCT05041023CompletedPrimary
Experience of Relatives and Intensive Care Units Caregivers of Controlled Donation After Circulatory Death
NCT05677789Unknown
Defining COVID-19 Infection Severity on Presentation to Hospital
NCT05675761Unknown
The Efficacy and Safety of Azovudine in the Treatment of COVID-19
Showing all 3 trials